Web-Based End-of-Life and Post-Mortem Care Education for Nursing Students
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNecmettin Erbakan University
About this trial
This study aims to evaluate the effect of a web-based end-of-life and post-mortem care education program on nursing students' post-mortem self-efficacy, death literacy, and attitudes toward the principles of a dignified death. Participants will receive educational content through an online learning platform, and the effectiveness of the program will be assessed using validated questionnaires administered before and after the intervention. The findings are expected to support the development of accessible, sustainable, and effective digital education programs that enhance nursing students' knowledge, skills, and attitudes related to end-of-life and post-mortem care.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Fourth-year undergraduate nursing students enrolled at the Faculty of Health Sciences, Necmettin Erbakan University, during the 2026-2027 Spring semester.
Successful completion of the Fundamentals of Nursing, Medical Nursing, and Psychiatric and Mental Health Nursing courses.
Access to an internet-enabled device.
Willingness to participate and provide informed consent.
Disqualifiers
Failure to complete at least one educational module.
Failure to complete the baseline, post-intervention, or follow-up assessments.
Withdrawal from the study at any time.
Trial design
Design model
Parallel
Treatments tested in this trial
Web-Based End-of-Life and Post-Mortem Care Education
BehavioralParticipants assigned to the experimental group will receive a web-based educational program consisting of eight structured online modules covering end-of-life and post-mortem care. The program is delivered through a dedicated web-based learning platform and includes narrated presentations, visual materials, case-based learning activities, and interactive educational resources. The intervention is designed to be completed over a two-month period, with sequential access to the modules to ensure completion of all educational content.
Face-to-Face Case Discussion Sessions
BehavioralParticipants assigned to the control group will participate in three face-to-face case discussion sessions focusing on end-of-life and post-mortem care according to the study protocol. During the intervention period, participants in the control group will not have access to the web-based educational platform. After completion of data collection, access to the web-based educational materials will be provided.
Treatment groups
74 Participants
are divided into 2 treatment groupsGroup A: Experimental GroupExperimental treatment 1 intervention
Group B: Control GroupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Post-Mortem Self-Efficacy
Change in nursing students' post-mortem self-efficacy will be measured using the End-of-Life and Post-Mortem Self-Efficacy Scale for Nursing Students. Total scores range from 0 to 100, with higher scores indicating greater self-efficacy in end-of-life and post-mortem care.
Time frame
Baseline, immediately after completion of the 2-month intervention (approximately 2 months), and 2-month follow-up (approximately 4 months from baseline).Secondary outcomes
1
Death Literacy
Change in nursing students' death literacy measured using the Death Literacy Index. Total scores range from 29 to 145, with higher scores indicating higher levels of death literacy.
Time frame
Baseline, immediately after completion of the 2-month intervention (approximately 2 months), and 2-month follow-up (approximately 4 months from baseline).2
Attitudes Toward the Principles of a Dignified Death
Change in nursing students' attitudes toward the principles of a dignified death measured using the Attitudes Toward the Principles of a Dignified Death Scale. Total scores range from 12 to 60, with higher scores indicating greater endorsement of the principles of a dignified death.
Time frame
Baseline, immediately after completion of the 2-month intervention (approximately 2 months), and 2-month follow-up (approximately 4 months from baseline).Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: